Jeff Yass’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
Jeff Yass's OVID Position: Q3 2026 in Review
Jeff Yass reduced its Ovid Therapeutics (OVID) stake by 59% in Q3 2026, selling an estimated $109K and leaving 28,913 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #12739.
Jeff Yass first reported a position in OVID in Q4 2019 and has held it in 22 quarters since. The position peaked at $4.32M in Q1 2026. 123 funds tracked by Wall St. Rank hold OVID as of Q3 2026.
- Jeff Yass held 28,913 shares of Ovid Therapeutics worth $72K as of Q3 2026.
- Jeff Yass sold 41,687 Ovid Therapeutics shares in Q3 2026, an estimated $109K.
- Ovid Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12739 holding.
- Jeff Yass first reported a position in Ovid Therapeutics in Q4 2019 and has held it in 22 quarters since.
- Jeff Yass's Ovid Therapeutics position peaked at $4.32M in Q1 2026.
- 123 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.